Literature DB >> 33796195

[Diagnosis and management of severe neonatal thrombocytopenia due to maternal alloimmunization against fetal platelet antigens: case study and literature review].

Jihane Toughza1, Aomar Agadr2, Mouad Nejjari1, Insaf Al Ammari1.   

Abstract

Thrombocytopenia is a common hematologic disorder in the neonatal period. It can occur in neonates hospitalized in the Intensive Care Unit and in preterm infants. It is characterized by a platelet count of less than 150.000/mm3. In the context of immune thrombocytopenia, neonatal thrombocytopenia due to maternal alloimmunization (estimated at 1 per 1000 live births) is not a rare event but it is often undiagnosed in minor forms. This is caused by maternal immunization against fetal platelet antigens inherited from the father and lacking in the mother. Maternal IgG alloantibodies cross the placenta causing fetal platelet destruction. In severe thrombocytopenia, consequences can be severe, with intracranial bleeding occurring in 10-30% of patients. Diagnosis is essentially based on clinical examination and must be suspected by pediatricians. Copyright: Jihane Toughza et al.

Entities:  

Keywords:  Severe neonatal thrombocytopenia; diagnosis; management; neonatal thrombocytopenia due to maternal alloimmunization

Mesh:

Substances:

Year:  2020        PMID: 33796195      PMCID: PMC7992410          DOI: 10.11604/pamj.2020.37.382.24325

Source DB:  PubMed          Journal:  Pan Afr Med J


  26 in total

1.  Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a.

Authors:  Marc L Turner; Hagop Bessos; Timothy Fagge; Mairi Harkness; Frances Rentoul; Janelle Seymour; David Wilson; Irene Gray; Ridheesh Ahya; John Cairns; Stan Urbaniak
Journal:  Transfusion       Date:  2005-12       Impact factor: 3.157

2.  Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IVIgG and steroids.

Authors:  G P Summerfield; A Beeby; D Bosman; C Chapman
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

Review 3.  Management of fetal and neonatal alloimmune thrombocytopenia.

Authors:  C Kaplan; F Forestier; F Daffos; G Tchernia; A Waters
Journal:  Transfus Med Rev       Date:  1996-07

Review 4.  Prenatal diagnosis and management of neonatal alloimmune thrombocytopenia.

Authors:  J A Johnson; G Ryan; A al-Musa; S Farkas; V S Blanchette
Journal:  Semin Perinatol       Date:  1997-02       Impact factor: 3.300

Review 5.  Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review.

Authors:  M M Kamphuis; N Paridaans; L Porcelijn; M De Haas; C E Van Der Schoot; A Brand; G J Bonsel; D Oepkes
Journal:  BJOG       Date:  2010-10       Impact factor: 6.531

6.  [Materno-fetal platelet allo-immunization revealed by in utero intracerebral fetal hemorrhage: proposed management for the next pregnancy].

Authors:  D Vauthier-Brouzes; G Lefebvre; P Saada; Y Darbois; C Kaplan
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2000-02

7.  Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT).

Authors:  Volker Kiefel; Dirk Bassler; Hartmut Kroll; Bosco Paes; Günter Giers; Juliana Ditomasso; Heidemarie Alber; Monika Berns; Bea Wiebe; Ernst-Markus Quenzel; Jochen Hoch; Andreas Greinacher
Journal:  Blood       Date:  2006-01-10       Impact factor: 22.113

Review 8.  A systematic review and survey of the management of unexpected neonatal alloimmune thrombocytopenia.

Authors:  Dirk Bassler; Andreas Greinacher; Chusak Okascharoen; Anne Klenner; Juliana Ditomasso; Volker Kiefel; Anthony Chan; Bosco Paes
Journal:  Transfusion       Date:  2007-09-24       Impact factor: 3.157

Review 9.  Antepartum fetal intracranial hemorrhage, predisposing factors and prenatal sonography: a review.

Authors:  D M Sherer; A Anyaegbunam; C Onyeije
Journal:  Am J Perinatol       Date:  1998-07       Impact factor: 1.862

10.  Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets.

Authors:  C Kaplan; F Daffos; F Forestier; W L Cox; D Lyon-Caen; M C Dupuy-Montbrun; C Salmon
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.